Monthly Archives: October 2011

The 5th Annual Digital Pharma East Conference

Posted on October 20, 2011 by Mark Senak

This week Manhattan Research released results from a new survey that showed that 26% of U.S. adults have used their mobile telephones to access health information on the Internet in the past 12 months.  The release of such a statistic … Continue reading →

Posted in New and Social Media | 2 Comments

Handy Twitter Lists

Posted on October 18, 2011 by Mark Senak

Twitter has emerged as one of the most active platforms for pharmaceutical companies and healthcare alike.  All major government agencies working in healthcare are now on Twitter and there are at least 124 pharma and device twitter feeds (certainly more) … Continue reading →

Posted in New and Social Media | 3 Comments

Warning and NOV Letter Summary – 3rd Quarter 2011

Posted on October 13, 2011 by Mark Senak

Last week it was noted that enforcement at DDMAC, newly renamed the Office of Prescription Drug Promotion (OPDP)  has slowed down.  Last quarter, the division, now an office, issued only four letters.  Not only is it worthwhile to look at … Continue reading →

Posted in Warning Letters | 2 Comments

FDA Needs Communications Expert Support

Posted on October 11, 2011 by Mark Senak

On October 3, FDA’s Center for Devices and Radiological Health (CDRH) issued a press release entitled “FDA outlines plans for an outside network of scientific experts“.  The release states that the purpose of the effort is to “plan to create … Continue reading →

Posted in FDA Policy, New and Social Media | 1 Comment

Weekly Roundup 10-7-11

Posted on October 7, 2011 by Mark Senak

We saw the sun this week in Washington for the first time in about a month.  It was great fun.  One hopes that the clearing of the gloom will have other effects. Lots happened this week.  Here are a few … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 10-7-11